We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aurora Spine Corporation | TSXV:ASG | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.005 | -1.79% | 0.275 | 0.26 | 0.30 | 0.275 | 0.275 | 0.275 | 6,030 | 21:00:02 |
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES
To our Shareholders:2017 was a productive year for Aurora Spine. During 2017 we continued the integration of our family of products into our Screwless Procedure™, a cutting-edge surgical approach to spine fusion. The Screwless Procedure features: our ZIP® MIS Fusion Systems, our TiNano® Interbody cages, and our COMPASS 4D™ MIS lateral retractor system.
Highlights from 2017
Highlights subsequent to year end
In 2017, we continued driving growth by training surgeons and distributors on Aurora Spine’s unique technology and increasing the reach of our sales force.
The management team also was able to achieve lower manufacturing costs on most of its Ti-PEEK products. As such, within cost of sales, Aurora recorded a non-cash adjustment to the inventory standard cost of these products, resulting in a one-time write down of approximately $405K. The adjustment resulted in a 7% decrease in gross margin for the year. Without the adjustment, margins would be little changed from the previous year. More importantly, going forward, the gross profit margin on these products will increase reflecting the lower inventory cost on the Company’s balance sheet.
We are optimistic about 2018. We have added some outstanding surgeons to our customer base that value our products and wish to be a part of our success. We continue to review our new product development within the framework of financial responsibility to achieve our long-term growth and profitability objectives.
We remain fully committed to developing our U.S. sales through engaging new and existing distributors and improving our direct relationship experience with our surgeons. This should allow us to generate increased sales and provide improved customer service going forward. In 2018 we also expect to strengthen our sales team in the U.S.
We are certain that these initiatives will create value for our shareholders. Management and I thank our shareholders for their continued support in these endeavors.
None of this would be possible without the dedication and commitment of our hardworking colleagues at Aurora. I want to thank them for the great accomplishments they have made this year, for Aurora and ultimately, for patients. They have embraced change and risen to the numerous challenges before them, and I am grateful for their ongoing support of our company and our mission.
I would also like to thank you, our investors, for your continued support. Together, we have built a strong foundation, and I look forward to the opportunities ahead of us. I am truly grateful to be part of an organization that makes such a positive improvement in the lives of patients around the world.
The Financial Statements together with the Management Discussion and Analysis can be found on SEDAR at www.sedar.com.
Trent J. NorthcuttPresident and Chief Executive Officer
About Aurora Spine Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
For more information, please contact:
Aurora Spine Corporation Trent Northcutt Sarina MasonPresident and Chief Executive Officer Chief Financial Officer(760) 424-2004 (760) 424-2004
1 Year Aurora Spine Chart |
1 Month Aurora Spine Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions